Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jack B. Goon
Observed names:
J.B. Goon,
Jack B Goon,
Jack Goon
Institution:
University of California Davis Medical Center
Observed institutions:
University of California Davis Medical Center,
UC Davis Comprehensive Cancer Center,
NeoImmuneTech, Inc. (United States),
University of California, Davis
ORCID:
0000-0001-5643-5028
Observed ORCID:
0000-0001-5643-5028
OpenAlex ID:
A5018637017
Sequential perturbations to mouse corticogenesis following in utero maternal immune activation
2021
·
Cesar P. Canales
, Myka L. Estes
, et al.
·
eLife
·
46
Advancements of Common Gamma-Chain Family Cytokines in Cancer Immunotherapy
2022
·
Alexandra A. Wolfarth
, Swati Dhar
, et al.
·
Immune Network
·
23
The Role of Interleukin-7 in the Formation of Tertiary Lymphoid Structures and Their Prognostic Value in Gastrointestinal Cancers
2022
·
Michael Brandon Ware
, Alexandra A. Wolfarth
, et al.
·
Journal of Immunotherapy and Precision Oncology
·
22
PDF
MHC class I upregulation contributes to the therapeutic response to radiotherapy in combination with anti-PD-L1/anti-TGF-β in squamous cell carcinomas with enhanced CD8 T cell memory-driven response
2024
·
Hanne T. Lind
, Spencer C. Hall
, et al.
·
Cancer Letters
·
19
PDF
Spatial Transcriptomic Landscape of Canine Oral Squamous Cell Carcinoma
2025
·
Stephanie Goldschmidt
, Clifford G. Tepper
, et al.
·
Molecular Carcinogenesis
·
6
PDF
657 NT-I7, a long-acting IL-7, plus pembrolizumab favors CD8 T-cell infiltration in liver metastases of heavily pre-treated, immunologically cold, MSS-colorectal and pancreatic cancer
2022
·
Aung Naing
, Sara Ferrando-Martinez
, et al.
·
Journal for ImmunoTherapy of Cancer
·
3
PDF
Author response: Sequential perturbations to mouse corticogenesis following in utero maternal immune activation
2021
·
Cesar P Canales
, Myka L Estes
, et al.
·
eLife
·
3
1674P NT-I7 plus pembrolizumab combination treatment enhances infiltration of PD-1+ T cells and provides a more immunogenic tumor microenvironment: Biomarker data from the NIT-110 study
2022
·
A. Naing
, S. Ferrando-Martinez
, et al.
·
Annals of Oncology
·
2
Ectopic integrin β1 overproduction by squamous carcinoma cells contributes to immune evasion-associated metastasis
2026
·
John D. Aleman
, Christian D. Young
, et al.
·
Cancer Letters
·
1
652 NT-I7 (efineptakin alfa), a long-acting IL-7, in combination with pembrolizumab improves T cell fitness in heavily pretreated subjects with gastrointestinal tumors
2023
·
Aung Naing
, Hirva Mamdani
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
PDF
777 Natural killer cells are prognostic for head and neck squamous cell carcinoma patients treated with radiation therapy, which induces cancer cell immunogenicity in preclinical models
2025
·
Jack B Goon
, Hanne Lind
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Abstract 6646: Investigating the combination of radiation and subsequent immune checkpoint inhibitor treatment in head and neck squamous cell carcinoma models
2024
·
Hanne Lind
, Alexander Strait
, et al.
·
Cancer Research
Show more works
View as search
Works count:
12
Citation count:
126
H-index:
5
I10-index:
4
Year
Topic
Type